Cost effectiveness of direct acting antivirals in the treatment of hepatitis C in vulnerable populations.

Hepatitis C Virus (HCV) is recognized as a prominent medical concern, being a common cause of cirrhosis, a risk factor for hepatocellular carcinoma, and a leading indication for liver transplantati...